‘How to’ – Stability Studies

Stability testing is a critical aspect of pharmaceutical development and quality assurance. Ensuring compliance with global stability testing requirements is essential for the approval, distribution, and maintenance of drug products in international markets. The guidelines set by regulatory authorities such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO) provide a structured framework for evaluating the stability of drugs and drug products under various environmental conditions. Compliance with these requirements is crucial for protecting public health, maintaining drug efficacy, and ensuring product safety throughout its shelf life.
Click to read the full article.

Fixed-dose combination (FDC) products combine two or more active pharmaceutical ingredients (APIs) in a single dosage form. Conducting stability studies for these products is crucial to ensure their safety, efficacy, and quality throughout their shelf life. The stability of each API in the combination must be evaluated under various environmental conditions to meet the requirements set by regulatory authorities such as the US FDA, EMA, and WHO. This guide outlines the steps to conduct stability studies for FDC products in compliance with global regulatory guidelines.
Click to read the full article.

ICH Q9 provides a systematic approach to risk management in the pharmaceutical industry, including stability testing. Effective implementation of ICH Q9 ensures that risks associated with stability testing are identified, evaluated, and controlled to maintain drug product quality. This guide explores the steps for implementing ICH Q9 in stability testing, enhancing compliance and risk mitigation strategies.
Click to read the full article.

Topical products, such as creams, ointments, and lotions, require specific stability studies to ensure their safety and efficacy over time. Compliance with US FDA and EMA guidelines is critical to obtaining regulatory approval and maintaining market access. This guide provides a detailed approach to conducting stability studies for topical products in compliance with these regulatory standards.
Click to read the full article.

Stability testing is a crucial component of Investigational New Drug (IND) applications, ensuring that investigational products remain safe and effective throughout clinical trials. Understanding and meeting the stability testing requirements set by regulatory authorities, such as the US FDA, is essential for the successful approval of IND applications. This guide outlines the steps to address these requirements effectively.
Click to read the full article.

Drug-device combination products, which integrate both pharmaceutical and medical device components, require specific stability testing to ensure the safety, efficacy, and functionality of the combined product. The ICH Q1A(R2) guidelines provide a comprehensive framework for conducting stability testing of these products. This guide outlines the steps to apply ICH Q1A(R2) to stability testing of drug-device combinations effectively.
Click to read the full article.

Stability studies are critical to ensuring the safety and efficacy of pharmaceutical products throughout their shelf life. The Brazilian Health Regulatory Agency (ANVISA) provides specific guidelines for conducting stability studies, tailored to the unique environmental conditions in Brazil. Adhering to these guidelines is essential for pharmaceutical companies seeking to market their products in Brazil. This guide provides a detailed approach to conducting stability studies in compliance with ANVISA regulations.
Click to read the full article.

Large molecule drugs, such as biologics and monoclonal antibodies, present unique stability challenges due to their complex structures and sensitivity to environmental conditions. The US FDA provides specific guidelines for conducting stability testing on these products to ensure their safety and efficacy. This guide outlines the steps for implementing stability testing for large molecule drugs in compliance with FDA regulations.
Click to read the full article.

Temperature-sensitive biologics, such as vaccines and gene therapies, require rigorous stability testing to ensure they maintain their safety, efficacy, and quality throughout their shelf life. Regulatory authorities, including the US FDA, EMA, and WHO, have established guidelines to govern stability testing for these sensitive products. This guide provides a comprehensive approach to conducting stability testing for temperature-sensitive biologics in compliance with these regulations.
Click to read the full article.

Drugs intended for special populations, such as pediatric, geriatric, or pregnant patients, require tailored stability testing to ensure their safety and efficacy. Regulatory authorities, including the US FDA, EMA, and WHO, have specific guidelines for stability testing of drugs used in these populations. This guide outlines the steps to address stability testing requirements for drugs in special populations, ensuring compliance with global regulations.
Click to read the full article.